Literature DB >> 12413674

The use of a leg holder immobilisation device in 3D-conformal radiation therapy of prostate cancer.

Brigitta G Baumert1, Oguzhan Zagralioglu, J Bernard Davis, Beatrice Reiner, Urs M Luetolf, Ilja F Ciernik.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate the impact of a leg holder immobilisation device on patient positioning accuracy in the treatment of prostate cancer.
MATERIAL AND METHODS: Twenty patients of similar age and stage of disease treated with curative external beam radiotherapy for prostate cancer were included prospectively. Ten patients were sequentially allocated to one of the two groups, and treated either with or without a leg holder. Treatment set-up alignment accuracy was assessed with an electronic portal imaging device (EPID).
RESULTS: Set-up accuracy was 0.3, 0.3 and 0.2 cm for patients with a leg holder, and 0.3, 0.4 and 0.2 cm for patients without a leg holder in the cranio-caudal, anterior-posterior and in the lateral positions, respectively. The difference is not significant. The repositioning accuracy of combined (sagittal and lateral) in-plane rotations on the other hand, was significantly improved with a leg holder device (P = 0.04).
CONCLUSIONS: Set-up accuracy can be improved using a leg holder immobilisation device in terms of rotational movement accuracy, thus making on-line corrections more accurate using EPID in the treatment of prostate cancer. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12413674     DOI: 10.1016/s0167-8140(02)00169-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  Intrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT.

Authors:  Judit Boda-Heggemann; Frederick Marc Köhler; Hansjörg Wertz; Michael Ehmann; Brigitte Hermann; Nadja Riesenacker; Beate Küpper; Frank Lohr; Frederik Wenz
Journal:  Radiat Oncol       Date:  2008-11-05       Impact factor: 3.481

2.  Accuracy and reproducibility of conformal radiotherapy using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).

Authors:  S Stanley; S Griffiths; M R Sydes; A R Moore; I Syndikus; D P Dearnaley
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-06-18       Impact factor: 4.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.